The cross-talk between MSCs and tumor cells also involves the activation of pro-inflammatory and pro-survival signaling pathways, including the NF-κB, PI3K/Akt, Wnt, MAPK, and JAK/STAT pathways, which play a role in tumor progression, metastasis formation, and angiogenesis. Here, NFKB1 is linked to neoplasm.